Geraldine O’Sullivan Coyne to lead early-stage clinical trials at Northwell’s START Center for Cancer Research

Monica Bertagnolli elected president of the National Academy of Medicine

Monica Bertagnolli, former director of NIH, has been elected by members of the National Academy of Medicine as the Academy’s next president.

January 23, 2026

Vol.52 No.03

In Brief

Elizabeth Jaffee and Antoni Ribas named editors-in-chief of the AACR JournalCancer Immunology Research

The American Association for Cancer Research announced the appointment of Elizabeth M. Jaffee and Antoni Ribas as editors-in-chief of Cancer Immunology Research. xxx:moreCancer Immun

January 23, 2026

Vol.52 No.03

In Brief

Kathie-Ann Joseph to lead breast surgery program at Rutgers & RWJBarnabas Health

Kathie-Ann Joseph was appointed chief of breast surgery and co-director of the multidisciplinary breast program at Rutgers Cancer Institute and the Jack & Sheryl Morris Cancer Center at RWJBarnabas Health.

January 23, 2026

Vol.52 No.03

In Brief

NRG announces chairs and vice-chairs across committees

NRG Oncology has announced changes in leadership across multiple committees.

January 23, 2026

Vol.52 No.03

In Brief

Johns Hopkins opens submissions for Terry and Elliott Langbaum Endowed Award and lecture on innovation in academic medicine

Johns Hopkins is seeking nominations for the Langbaum award, endowed by Elliott Langbaum and family. The award is in honor of Terry Langbaum, a long-time administrator at The Kimmel Cancer Center.

January 23, 2026

Vol.52 No.03

Clinical Roundup

Trodelvy + Keytruda show potential as new standard of care in first-line PD-L1+ metastatic TNBC, phase III trial finds

Patients saw a 35% reduced risk of disease progression or death for Trodelvy (sacituzumab govitecan-hziy) plus Keytruda (pembrolizumab) (n=221) versus standard of care Keytruda plus chemotherapy (n=222), according to the positive phase III ASCENT-04/KEYNOTE-D19 study evaluating the combination of Trodelvy plus Keytruda in first-line PD-L1+ (CPS ≥10) metastatic triple-negative breast cancer.

January 23, 2026

Vol.52 No.03

Geraldine O’Sullivan Coyne to lead early-stage clinical trials at Northwell’s START Center for Cancer Research

YOU MAY BE INTERESTED IN

Monica Bertagnolli elected president of the National Academy of Medicine

Elizabeth Jaffee and Antoni Ribas named editors-in-chief of the AACR JournalCancer Immunology Research

Kathie-Ann Joseph to lead breast surgery program at Rutgers & RWJBarnabas Health

NRG announces chairs and vice-chairs across committees

Johns Hopkins opens submissions for Terry and Elliott Langbaum Endowed Award and lecture on innovation in academic medicine

Trodelvy + Keytruda show potential as new standard of care in first-line PD-L1+ metastatic TNBC, phase III trial finds

Renew today!

Subscriber content

Never miss an issue!

Login